Human immunodeficiency virus associated central nervous system infections

Practical Neurology

Volumn 5, Issue 6, 2005, Pages 334-349

  Torok, M E ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; ATOVAQUONE; AZITHROMYCIN; CIDOFOVIR; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; CYTARABINE; DAPSONE; DEXAMETHASONE; DOXYCYCLINE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; FLUOROURACIL; FOLINIC ACID; FOSCARNET; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; MINOCYCLINE; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; SULFADIAZINE; UNINDEXED DRUG; VORICONAZOLE;

BEAM THERAPY; BONE MARROW SUPPRESSION; BRAIN BIOPSY; BRAIN SCINTISCANNING; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EPSTEIN BARR VIRUS; FUNGAL MENINGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRACRANIAL PRESSURE; JC VIRUS; LUMBAR PUNCTURE; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MONOTHERAPY; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; VIRUS ENCEPHALITIS;

EID: 29744442324     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-7766.2005.00345.x     Document Type: Review

References (192)

1. Abgrall S, Rabaud C & Costagliola D (2001) Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clinical Infection and Disease, 33, 1747-55.
2. Albrecht H et al. (1998) Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. Aids, 12, 1149-54.
3. Ammassari A et al. (1998) Changing disease patterns in focal brain lesion-causing disorders in AIDS. Journal of Acquired Immune Deficiency Syndrome & Human Retrovirology, 18, 365-71.
4. Anduze-Faris BM et al. (2000) Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. Aids, 14, 517-24.
5. Antinori A et al. (1997) Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology, 48, 687-94.
6. Arribas JR et al. (1995) Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. Journal of Infection and Disease, 172, 527-31.
7. Arribas JR et al. (1996) Cytomegalovirus encephalitis. Annals of Internal Medicine, 125, 577-87.
8. Ashby M & Grant H (1955) Tuberculous meningitis treated with cortisone. Lancet, 268, 65-6.
9. Baldeweg T & Catalan J (1997) Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet, 349, 1554-5.
10. Baqi M, Kucharczyk W & Walmsley SL (1997) Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy. Aids, 11, 1526-7.
11. Baumgartner JE et al. (1990) Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. Journal of Neurosurgery, 73, 206-11.
12. Benson CA et al. (2004) Treating Opportunistic Infections Among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recommendations and Report, 53(RR-15), 1-112.
13. Berenguer J et al. (1992) Tuberculous meningitis in patients infected with the human immunodeficiency virus. New England Journal of Medicine, 326, 668-72.
14. Berger JR et al. (1987) Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Annals of Internal Medicine, 107, 78-87.
15. Berger JR & Mucke L (1988) Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology, 38, 1060-5.
16. Berger JR et al. (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. Journal of Neurovirology, 4, 59-68.
17. Berger JR & Major EO (1999) Progressive multifocal leukoencephalopathy. Seminal Neurology, 19, 193-200.
18. Berman SM & Kim RC (1994) The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. American Journal of Medicine, 96, 415-9.
19. Bhargava S, Gupta AK & Tandon PN (1982) Tuberculous meningitis-a CT study. British Journal of Radiology, 55, 189-96.
20. Blumberg HM et al. (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. American Journal of Respiratory Critical Care Medicine, 167, 603-62.
21. Bonington A et al. (2000) TB PCR in the early diagnosis of tuberculous meningitis: evaluation of the Roche semi-automated COBAS Amplicor MTB test with reference to the manual Amplicor MTB PCR test. Tuberculous Lung Disease, 80, 191-6.
22. Boska MD et al. (2004) Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring. Current HIV Research, 2, 61-78.
23. Bower M et al. (1999) Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. European Journal of Cancer, 35, 601-4.
24. Brambilla AM et al. (1999) Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. Journal of Neurology, 246, 723-5.
25. Brouwer AE et al. (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet, 363, 1764-7.
26. Bullock MR & Welchman JM (1982) Diagnostic and prognostic features of tuberculous meningitis on CT scanning. Journal of Neurology, Neurosurgury, & Psychiatry, 45, 1098-101.
27. Burns DK, Risser RC & White CL 3rd (1991) The neuropathology of human immunodeficiency virus infection. The Dallas, Texas, experience. Archives of Pathological Laboratory Medicine, 115, 1112-24.
28. Centers for Disease Control and Prevention. Treating opportunistic imfections among HIV-infected adults and adolescents: recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004,53, no. RR-15.
29. Chamberlain MC & Kormanik PA (1999) AIDS-related central nervous system lymphomas. Journal of Neurooncology, 43, 269-76.
30. Chowdhury M et al. (1992) Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. Journal of Virology, 66, 7355-61.
31. Ciacci JD et al. (1999) Lymphoma of the central nervous system in AIDS. Seminal Neurology, 19, 213-21.
32. Cingolani A et al. (1996) PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. Journal of Medical Microbiology, 45, 472-6.
33. Cingolani A et al. (1998) Minimally invasive diagnosis of acquired immunodeficiency syndyome-related primary central nervous system lymphoma. Journal of the National Cancer Institute, 90, 364-9.
34. Cinque P et al. (1995) Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. Journal of Infection and Disease, 171, 1603-6.
35. Cinque P et al. (1996) Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. Aids, 10, 951-8.
36. Cinque P et al. (1997) Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. Aids, 11, 1-17.
37. Cinque F, Casari S & Bertelli D (1998) Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy. New England Journal of Medicine, 339, 848-9.
38. Clifford DB et al. (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology, 52, 623-5.
39. Cohen BA (1999) Neurologic manifestations of toxoplasmosis in AIDS. Seminars in Neurology, 19, 201-11.
40. Collazos J et al. (1999) Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. Aids, 13, 1426-8.
41. Conti S et al. (2000) Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. Journal of Acquired Immune Deficiency Syndrome, 25, 451-8.
42. Cote TR et al. (1996) Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. Journal of the National Cancer Institute, 88, 675-9.
43. Crofton J (1987) The prevention and management of drug-resistant tuberculosis. Bulletin of the International Union of Tuberculous Lung Disease, 62, 6-11.
44. D'Amico A et al. (1997) Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nuclear Medical Communications, 18, 741-50.
45. Dastur DK, Manghani DK & Udani PM (1995) Pathology and pathogenetic mechanisms in neurotuberculosis. Radiological Clinical North America, 33, 733-52.
46. De La Pena RC, Ketonen L & J Villanueva-Meyer (1998) Imaging of brain tumors in AIDS patients by means of dual-isotope thallium-201 and technetium-99m sestamibi single-photon emission tomography. European Journal of Nuclear Medicine, 25, 1404-11.
47. De Luca A et al. (1996) Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. Journal of Clinical Microbiology, 34, 1343-6.
48. De Luca A et al. (1999a) Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clinical Infection and Disease, 28, 624-8.
49. De Luca A et al. (1999b) Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology, 52, 891-2.
50. De Luca A et al. (2000) The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. Journal of Infection and Disease, 182, 1077-83.
51. Donahue BR, Sullivan JW & Cooper JS (1995) Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer, 76, 328-32.
52. Donald PR & Seifart HI (1989) Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. Journal of Pediatrics, 115, 483-6.
53. Dooley DP, Carpenter JL & Rademacher S (1997) Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clinical Infection and Disease, 25, 872-87.
54. Dube MP, Holtom PD & Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. American Journal of Medicine, 93, 520-4.
55. Dworkin MS et al. (1999) Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. Journal of Infection and Disease, 180, 621-5.
56. Elliot B et al. (1997) 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet, 349, 850.
57. Escobar JA et al. (1975) Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics, 56, 1050-5.
58. Ferrante P et al. (1995) PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. Journal of Medical Virology, 47, 219-25.
59. Fessler RD et al. (1998) Management of elevated intracranial pressure in patients with Cryptococcal meningitis. Journal of Human Immune Deficiency Syndromes and Human Retrovirology, 17, 137-42.
60. Fine HA & Mayer RJ (1993) Primary central nervous system lymphoma. Annals of Internal Medicine, 119, 1093-104.
61. Fong IW & Toma E (1995) The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group. Clinical Infection and Disease, 20, 1305-10.
62. Gaidano G, Carbone A & Dalla-Favera R (1998) Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. American Journal of Pathology, 152, 623-30.
63. Gal AA, Evans S & Meyer PR (1987) The clinical laboratory evaluation of cryptococcal infections in the acquired immunodeficiency syndrome. Diagnosis of Microbiological Infection and Disease, 7, 249-54.
64. Garcia de Viedma D et al. (1999) Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. Journal of Clinical Microbiology, 37, 724-8.
65. Garg RK (1999) Tuberculosis of the central nervous system. Postgraduate Medical Journal, 75, 133-40.
66. Gasnault J et al. (1999) Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. Journal of Neurovirology, 5, 421-9.
67. Gasnault J et al. (2001) Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. Journal of Neurovirology, 7, 375-81.
68. Girgis NI et al. (1983) The use of dexamethasone in preventing ocular complications in tuberculous meningitis. Transactions of the Royal Society of Tropical Medical Hygiene, 77, 658-9.
69. Girgis NI et al. (1991) Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatrics Infection and Disease Journal, 10, 179-83.
70. Girgis NI et al. (1998) Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. American Journal of Tropical Medical Hygiene, 58, 28-34.
71. Giudici B et al. (2000) Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clinical Infection and Disease, 30, 95-9.
72. Goldstein JD et al. (1991) Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation. Cancer, 67, 2756-65.
73. Gozlan J et al. (1992) Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. Journal of Infection and Disease, 166, 1416-21.
74. Grant IH et al. (1990) Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. Aids, 4, 519-21.
75. Graybill JR et al. (2000) Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clinical Infection and Disease, 30, 47-54.
76. Grulich AE (1999) AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 21 (Suppl. 1), S27-S30.
77. Hall CD et al. (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. New England Journal of Medicine, 338, 1345-51.
78. Heald AE et al. (1996) Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). International Journal of STD AIDS, 7, 337-46.
79. Hellerbrand C, Goebel FD & Disko R (1996) High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. European Journal of Clinical Microbiological Infection and Disease, 15, 869-72.
80. Hoffman JM et al. (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. Journal of Nuclear Medicine, 34, 567-75.
81. Holland NR et al. (1994) Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology, 44, 507-14.
82. Holloway RG & Mushlin AI (1996) Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology, 46, 1010-15.
83. Holman RC et al. (1991) Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology, 41, 1733-6.
84. Hosoglu S et al. (2002) Predictors of outcome in patients with tuberculous meningitis. International Journal of Tuberculous Lung Disease, 6, 64-70.
85. Hsieh FY, Chia LG & Shen WC (1992) Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology, 34, 197-9.
86. Inui K et al. (1999) Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain and Development, 21, 416-9.
87. Jacomet C et al. (1997) Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. Aids, 11, 1725-30.
88. Janssen RS (1997) Epidemiology and neuroepidemiology of human immunodeficiency virus infection. In: AIDS and the Central Nervous System (ed. Levy RM), pp. 13-37. Lippincott-Raven, Philadeplhia.
89. Joint Tuberculosis Committee of the British Thoracic Society (1998) Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax, 53, 536-48.
90. Kalayjian RC et al. (1993) Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine (Baltimore), 72, 67-77.
91. Karahalios D et al. (1992) Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. Journal of Acquired Immune Deficiency Syndrome, 5, 1030-8.
92. Karstaedt AS et al. (1998) Tuberculous meningitis in South African urban adults. Quarterly Journal of Medicine, 91, 743-7.
93. Katrak SM et al. (2000) The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. Journal of Neurological Science, 181, 118-26.
94. Katz RL et al. (1989) Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection. Acta Cytologica, 33, 233-44.
95. Kennedy DH & Fallon RJ (1979) Tuberculous meningitis. Journal of the American Medical Association, 241, 264-8.
96. Khan ZK et al. (1996) Cryptococcosis associated with HIV negative Indian patients and HIV positive Indian blood donors. Zentralblatt fur Bakteriology, 283, 360-74.
97. Koralnik IJ, Du Pasquier RA & Letvin NL (2001) JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. Journal of Virology, 75, 3483-7.
98. Krupp LB et al. (1985) Progressive multifocal leukoencephalopathy: clinical and radiographic features. Annals of Neurology, 17, 344-9.
99. Kumar R et al. (1996) Value of CT scan in the diagnosis of meningitis. Indian Pediatrics, 33, 465-8.
100. Kumarvelu S et al. (1994) Randomized controlled trial of dexamethasone in tuberculous meningitis. Tuberculous Lung Disease, 75, 203-7.
101. Kure K et al. (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Human Pathology, 22, 700-10.
102. Larsen RA et al. (1994) Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clinical Infection and Disease, 19, 741-5.
103. Laurenson IF, Ross JD & Milne LJ (1998) Microscopy and latex antigen negative cryptococcal meningitis. Journal of Infection, 36, 329-31.
104. Lee VW et al. (1999) Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology, 211, 507-12.
105. Leenders AC et al. (1994) Cryptococcal meningitis in HIV-infected patients. Aids, 8, 1741-3.
106. Leenders AC et al. (1997) Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. Aids, 11, 1463-71.
107. Levy RM, Bredesen DE & Rosenblum ML (1985) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. Journal of Neurosurgery, 62, 475-95.
108. Levy RM & Rothholtz V (1997) HIV-1-related neurologic disorders. Neurosurgical implications. Neuroimaging Clinics of North America, 7, 527-59.
109. Lorberboym M et al. (1996) Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. Journal of Nuclear Medicine, 37, 1150-4.
110. Lorberboym M et al. (1998) Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. Journal of Nuclear Medicine, 39, 1366-9.
111. Luft BJ et al. (1984) Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. Journal of the American Medical Association, 252, 913-7.
112. Luft BJ & Remington JS (1992) Toxoplasmic encephalitis in AIDS, Clinical Infection and Disease, 15, 211-22.
113. Luft BJ et al. (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. New England Journal of Medicine, 329, 995-1000.
114. Major EO et al. (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clinical Microbiological Review, 5, 49-73.
115. Martinez E et al. (2000) Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. Aids, 14, 2615-7.
116. Maschke M et al. (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). Journal of Neurology, Neurosurgery, & Psychiatry, 69, 376-80.
117. Masliah E et al. (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. Aids, 14, 69-74.
118. McArthur J (1987) Neurologic manifestations of AIDS. Medicine (Baltimore), 66, 407-37.
119. McCutchan JA (1995) Cytomegalovirus infections of the nervous system in patients with AIDS. Clinical Infection and Disease, 20, 747-54.
120. McGowan JP & Shah S (1998) Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. Aids, 12, 952-4.
121. Metta HA et al. (2002) Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients. Review of Argentinian Microbiology, 34, 117-23.
122. Miller RE et al. (1998) Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sexually Transmitted Infection, 74, 258-64.
123. Miralles P et al. (1998) Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. Aids, 12, 2467-72.
124. Moore DA et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. Journal of Clinical Microbiology, 42, 4432-7.
125. Moreno S et al. (1996) Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clinical Infection and Disease, 23, 1066-8.
126. Morgello S et al. (1987) Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Human Pathology, 18, 289-97.
127. Murray H (1999) Toxoplasmosis. In: AIDS Therapy (ed. Saag M), p. 307-27. Churchill Livingstone, New York.
128. Nuckols JD et al. (1999) Primary central nervous system lymphomas: a 30-year experience at a single institution. Modern Pathology, 12, 1167-73.
129. O'Doherty MJ et al. (1997) PET scanning and the human immunodeficiency virus-positive patient. Journal of Nuclear Medicine, 38, 1575-83.
130. O'Malley JP et al. (1994) Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography. American Journal of Roentgenology, 163, 417-21.
131. O'Toole RD et al. (1969) Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy. Annals of Internal Medicine, 70, 39-48.
132. Oursler KA, Moore RD & Chaisson RE (1999) Risk factors for cryptococcal meningitis in HIV-infected patients. AIDS and Research Human Retroviruses, 15, 625-31.
133. Ozates M et al. (2000) CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiologica, 41, 13-7.
134. Perrons CJ et al. (1995) Progressive multifocal leukoencephalopathy in patients with AIDS: detection of JC virus DNA in CSF and brain. Genitourinary Medicine, 71, 35-40.
135. Petito CK et al. (1986) Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. Journal of Neuropathological Experimental Neurology, 45, 635-46.
136. Pierce MA et al. (1995) Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Annals of Internal Medicine, 123, 594-8.
137. Porter SB & Sande MA (1992) Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. New England Journal of Medicine, 327, 1643-8.
138. Post MJ et al. (1985) Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique. American Journal of Roentgenology, 145, 929-40.
139. Post MJ et al. (1999) Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. American Journal of Neuroradiology, 20, 1896-906.
140. Potasman I et al. (1988) Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine, 108, 49-51.
141. Powderly WG et al. (1992) A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. New England Journal of Medicine, 326, 793-8.
142. Raez LE et al. (1998) Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Critical Reviews in Oncology, 9, 199-208.
143. Raffi F et al. (1997) A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. Aids, 11, 177-84.
144. Renold C et al. (1992) Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore), 71, 224-39.
145. Revello MG et al. (1994) Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. Journal of Infection and Disease, 170, 1275-9.
146. Rich AR & McCordock HA (1933) The pathogenesis of tuberculous meningitis. Bulletin of the John Hopkins Hospital, 52, 5-37.
147. Roberts TC & Storch GA (1997) Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. Journal of Clinical Microbiology, 35, 268-9.
148. Robotin MC et al. (2004) Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-84.
149. Rodesch G et al. (1989) Nervous system manifestations and neuroradiologic findings in acquired immunodeficiency syndrome (AIDS). Neuroradiology, 31, 33-9.
150. Ruiz A et al. (1994) Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. American Journal of Neuroradiology, 15, 1885-94.
151. Ruiz A et al. (1997) Primary central nervous system lymphoma in patients with AIDS. Neuroimaging Clinics of North America, 7, 281-96.
152. Saag MS et al. (1999) A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal mmingitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clinical Infection and Disease, 28, 291-6.
153. Saag MS et al. (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clinical Infection and Disease, 30, 710-18.
154. Sacktor N et al. (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 56, 257-60.
155. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. Journal of Neurovirology, 8 (Suppl. 2), 115-21.
156. Sadler M, Brink NS & Gazzard BG (1998) Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Quartly Journal of Medicine, 91, 205-17.
157. Salazar A et al. (1995) Cytomegalovirus ventriculoencephalitis in AIDS patients. Scandinavian Journal of Infection and Disease, 27, 165-9.
158. Sanchez-Portocarrero J & Perez-Cecilia E (1997) Intracerebral mass lesions in patients with human immunodeficiency virus infection and cryptococcal meningitis. Diagnostic Microbiology and Infectious Diseases, 29, 193-8.
159. Silber E et al. (1998) Dual infective pathology in patients with cryptococcal meningitis. Neurology, 51, 1213-5
160. Simpson DM & Tagliati M (1994) Neurologic manifestations of HIV infection. Annals of Internal Medicine, 121, 769-85.
161. Skiest DJ et al. (2000) SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. Journal of Infection, 40, 274-81.
162. Skiest DJ & Crosby C (2003) Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. Aids, 17, 1787-93.
163. Skolasky RL et al. (1999) HIV-associated primary CNS lymorbidity and utility of brain biopsy. Journal of Neurological Science, 163, 32-8.
164. So YT, Beckstead JH & Davis RL (1986) Primary central nervous system lymphoma in acquired immune deficiency syndrome. a clinical and pathological study. Annals of Neurology, 20, 566-72.
165. Stewart SM (1953) The bacteriological diagnosis of tuberculous meningitis. Journal of Clinical Pathology, 6, 241-2.
166. Tada H et al. (1990) Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proceedings of the National Academy of Sciences of the USA, 87, 3479-83.
167. Taoufik Y et al. (1998) Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Journal of Infection and Disease, 178, 1816-20.
168. Tassie JM et al. (1999) Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. Aids, 13, 1881-7.
169. Teofilo E et al. (1998) Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy. Aids, 12, 449.
170. Teoh R et al. (1989) Clinical correlation of CT changes in 64 Chinese patients with tuberculous meningitis. Journal of Neurology, 236, 48-51.
171. Thorner AR & Katz JT (2001) Progressive Multifocal Leukoencephalopathy. Current Infective Disease Report, 3, 352-9.
172. Thwaites GE et al. (2002a) Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet, 360, 1287-92.
173. Thwaites GE et al. (2002b) Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. International Journal of Tuberculous Lung Disease, 6, 865-71.
174. Thwaites GE, Chau TT & Farrar JJ (2004a) Improving the bacteriological diagnosis of tuberculous meningitis. Journal of Clinical Microbiology, 42, 378-9.
175. Thwaites GE et al. (2004b) Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. Journal of Clinical Microbiology, 42, 996-1002.
176. Thwaites GE et al. (2004c) Dexamethasone for the treatment of tuberculous meningitis in adults and children. New England Journal of Medicine, 351, 1741-51.
177. Tornatore C et al. (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Annals of Neurology, 31, 454-62.
178. Torok ME et al. (2005) Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections? Aids, 19, 535-6.
179. van der Horst CM et al. (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. New England Journal of Medicine, 337, 15-21.
180. van Loenhout-Rooyackers JH et al. (2001) Tuberculous meningitis: is a 6-month treatment regimen sufficient? International Journal of Tuberculous Lung Disease, 5, 1028-35.
181. Vibhagool A et al. (2003) Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clinical Infection and Disease, 36, 1329-31.
182. Villringer K et al. (1995) Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. Journal of Computer Assisted Tomography, 19, 532-6.
183. Wang CY, Snow JL & Su WP (1995) Lymphoma associated with human immunodeficiency virus infection. Mayo Clinical Proceedings, 70, 665-72.
184. Wang W & Carm AR (2001) Clinical manifestations of AIDS with cryptococcal meningitis. Chinese Medical Journal (English), 114, 841-3.
185. Weber T (1999) Cerebrospinal fluid analysis for the diagnosis of human immunodeficiency virus-related neurologic diseases. Seminal Neurology, 19, 223-33.
186. Wolf DG & Spector SA (1992) Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. Journal of Infection and Disease, 166, 1412-5.
187. Wong B et al. (1984) Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Annals of Internal Medicine, 100, 36-42.
188. Woods ML 2nd et al. (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. Aids, 12, 1491-4.
189. Wright D, Schneider A & Berger JR (1997) Central nervous system opportunistic infections. Neuroimaging Clinical North America, 7, 513-25.
190. Yechoor VK et al. (1996) Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Archives of Internal Medicine, 156, 1710-6.
191. Yiannoutsos CT et al. (1999) Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Annals of Neurology, 45, 816-21.
192. Zeind CS et al. (1996) Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. Pharmacotherapy, 16, 547-61.